Gina Consylman, Interim CFO and CAO at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 864 shares at $15.20 ($13K) on 2017-11-10, disclosed to the SEC on 2017-11-14.
Scheduled sale ($13k) by Interim CFO and CAO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IRWD | SELL | 2020-02-25 | $217K | — | Filing → |
| IRWD | SELL | 2019-11-12 | $17K | — | Filing → |
| IRWD | SELL | 2019-08-20 | $2K | — | Filing → |